PUBLISHER: The Business Research Company | PRODUCT CODE: 1947051
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947051
Refractive surgery devices and equipment are employed in procedures aimed at correcting or enhancing vision impaired by refractive errors, which can include conditions like near-sightedness (myopia), farsightedness (hyperopia), presbyopia, and astigmatism.
The primary product categories of refractive surgery devices and equipment include microkeratome, excimer lasers, femtosecond lasers, and YAG lasers. The excimer laser is a type of laser that emits highly concentrated light in the ultraviolet (UV) region of the electromagnetic spectrum. These devices are applied in various procedures addressing conditions such as astigmatism, near-sightedness, and farsightedness, and they find use in different healthcare settings, including hospitals, ambulatory surgical centers, and ophthalmology clinics.
Tariffs are influencing the refractive surgery devices and equipment market by increasing costs of imported lasers, optical components, precision electronics, and imaging modules used in excimer, femtosecond, and YAG laser systems. Ophthalmology clinics and surgical centers in North America and Europe are most affected due to reliance on imported high-end devices, while Asia-Pacific faces increased manufacturing and export costs. These tariffs are raising equipment acquisition costs and delaying technology upgrades. However, they are also supporting regional manufacturing, localized assembly, and innovation in cost-efficient refractive surgery platforms.
The refractive surgery devices and equipment market research report is one of a series of new reports from The Business Research Company that provides refractive surgery devices and equipment market statistics, including refractive surgery devices and equipment industry global market size, regional shares, competitors with a refractive surgery devices and equipment market share, detailed refractive surgery devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the refractive surgery devices and equipment industry. This refractive surgery devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The refractive surgery devices and equipment market size has grown strongly in recent years. It will grow from $1.02 billion in 2025 to $1.09 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increasing prevalence of refractive errors, rising patient awareness of laser eye surgeries, expansion of ophthalmic surgical centers, advancements in excimer laser technology, growing availability of outpatient refractive procedures.
The refractive surgery devices and equipment market size is expected to see strong growth in the next few years. It will grow to $1.39 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to growing demand for premium refractive surgery solutions, increasing adoption of bladeless lasik techniques, expansion of vision correction procedures in emerging markets, rising investments in advanced ophthalmic laser systems, continued innovation in eye-tracking and imaging technologies. Major trends in the forecast period include increasing adoption of femtosecond laser platforms, rising demand for minimally invasive vision correction procedures, growing integration of ai-based eye mapping systems, expansion of customized laser treatment profiles, enhanced focus on surgical precision and safety.
The expansion of healthcare infrastructure is anticipated to drive the growth of the refractive surgery devices and equipment market in the coming years. Healthcare infrastructure encompasses the physical and organizational assets, facilities, and systems that collectively enable the delivery of healthcare services within a specific region, community, or healthcare system. Healthcare infrastructure plays an essential role in supporting the refractive surgery devices and equipment market by ensuring the availability of required resources, facilities, and specialized expertise for refractive surgeries and related eye care services. For example, in December 2023, according to the Centers for Medicare & Medicaid Services (CMS), a U.S.-based federal agency, healthcare spending in the United States increased by 7.5% to reach US$4.9 trillion in 2023 compared to the previous year. Therefore, the growth in healthcare infrastructure is contributing to the expansion of the refractive surgery devices and equipment market.
Major companies operating in the refractive surgery devices and equipment market are innovating with new technological products, such as femtosecond laser systems, to enhance their profitability in the market. A femtosecond laser system emits optical pulses with a duration well below 1 picosecond, in the femtosecond range. For example, in August 2023, Johnson & Johnson Vision, a US-based ophthalmology company, introduced the ELITA platform. This platform incorporates the SILK method, an advanced corneal refractive technique that enables physicians to treat myopia in patients with astigmatism. Patients undergoing LASIK surgery or other refractive treatments can benefit from the ELITA System for creating a corneal flap.
In December 2023, Carl Zeiss Meditec AG, a Germany-based provider of medical technology solutions for ophthalmology, announced plans to acquire Dutch Ophthalmic Research Center (D.O.R.C.) for approximately USD 1,135.39 million (EUR 985 million). Through this acquisition, ZEISS seeks to strengthen its ophthalmic surgery portfolio and establish a more comprehensive, digitally connected surgical workflow encompassing both anterior and posterior eye surgeries, including refractive procedures. D.O.R.C. is a Netherlands-based manufacturer of surgical instruments, consumables, and liquids used in ophthalmic surgery.
Major companies operating in the refractive surgery devices and equipment market are Alcon, Johnson & Johnson, Carl Zeiss AG, Ziemer Ophthalmic Systems AG, Nidek Co. Ltd., STAAR Surgical Company, Avedro Inc., Lensar Inc., iVIS Technologies, SCHWIND eye-tech-solutions GmbH & Co. KG, Lumenis Ltd., Ellex Medical Lasers Limited, Visx, Refractec LLC, Topcon Corporation, HOYA Corporation, Glaukos Corporation, IRIDEX Corporation, Aaren-Scientific Inc., Lenstec Inc., Oculentis B.V., Ophtec B.V., Rayner Intraocular Lenses Limited, The HumanOptics AG, PhysIOL, Essilor International, NIDEK Co.Ltd., Quantel Medical SAS, Abbott Medical Optics Inc., Oertli Instrumente AG, Topcon Corporation, Ophtec USA Inc., VisionCare Ophthalmic Technologies Inc., Visioneering Technologies Inc., Z-LASER Optoelektronik GmbH,
North America was the largest region in the global refractive surgery devices (or) equipment market in 2025. Asia-Pacific was the second-largest region in the refractive surgery devices (or) equipment market. The regions covered in the refractive surgery devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the refractive surgery devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The refractive surgery devices and equipment market consist of sales of microkeratome, excimer lasers, femtosecond lasers, YAG lasers, and aberrometers that are used for refractive surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Refractive Surgery Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses refractive surgery devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for refractive surgery devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The refractive surgery devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.